Enhanced epithelial to mesenchymal transition and chemoresistance in advanced Retinoblastoma tumors is driven by miR-181a
V. Suresh Babu, A. Bisht, A. Mallipatna, D. SA, G. Dudeja, R. Kannan, R. Shetty, S. Heymans, N. Guha, A. Ghosh
This study identifies miR-181a-5p as a regulator of EMT and chemoresistance in advanced retinoblastoma by reversing drug resistance through targeting ZEB1 and SNAI2.
bioRxiv · Jul 25, 2022 · PreprintCancer Biology